As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Bill Martin, Global Therapeutic Area Head, Neuroscience at Johnson & Johnson Innovative Medicine. We discussed the challenges and opportunities ahead for the development of treatments for psychiatric disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiseman, S. In conversation with Bill Martin. Nat Neurosci 27, 211–215 (2024). https://doi.org/10.1038/s41593-023-01544-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41593-023-01544-9